• Team

    Coordination centre
    Charité - Universitätsmedizin Berlin
    Department of Dermatology, Venereology and Allergology
    Division of Immunology and Allergy
    led by Prof. M. Worm

    Europe

    • A. Muraro, Referral Centre for Food Allergy Veneto Region Department of Pediatrics – University of Padua, Italy
    • M. Fernandez-Rivas, Hospital Clinico San Carlos Madrid, Spain
    • D. Sabouraud, Allergyvigilance Network, Vandoeuvre les Nancy, France
    • M. Worm, Division of Immunology and Allergy, Department of Dermatology, Venereology and Allergology, Charité - Universitätsmedizin Berlin, Germany

    UK

    • PJ. Turner, Imperial College London, UK
    • MH. Gowland, Allergy Action - St Albans, UK
    • The British Society for Allergy & Clinical Immunology (BSACI), UK
    • Paediatric Emergency Research in the UK and Ireland (PERUKI), UK
    • M. Worm, Division of Immunology and Allergy, Department of Dermatology, Venereology and Allergology, Charité - Universitätsmedizin Berlin, Germany

    Brazil

    • LF. Ensina, Division of Allergy, Clinical Immunology and Rheumatology, Department of Pediatrics, Universidade Federal de São Paulo (UNIFESP), Brazil
    • M. Worm, Division of Immunology and Allergy, Department of Dermatology, Venereology and Allergology, Charité - Universitätsmedizin Berlin, Germany
  • Statistics

    Status: Wednesday, 05. November 2025

    14525 completed cases

    Male patients 6812 47%
    Female patients 7713 53%
    Children and youths 3498 24%
    Adults 11027 76%

    completed cases per country:

    Germany 10725 74%
    Austria 1200 8%
    Switzerland 2600 18%

    2772 completed cases

    Male patients 1501 54%
    Female patients 1271 46%
    Children and youths 1148 41%
    Adults 1624 59%

    3653 completed cases

    Male patients 2035 56%
    Female patients 1618 44%
    Children and youths 1434 39%
    Adults 2219 61%

    completed cases per country:

    Brazil 282 8%
    Bulgaria 256 7%
    Greece 434 12%
    Ireland 240 7%
    Italy 963 26%
    Poland 587 16%
    Spain 683 19%
    Romania 84 2%
    Netherlands 91 2%
    Croatia 33 1%

    347 completed cases

    Male patients 189 54%
    Female patients 158 46%
    Children and youths 305 88%
    Adults 42 12%